BamSEC and AlphaSense Join Forces
Learn More

Larimar Therapeutics Inc.

NASDAQ: LRMR    
Share price (1/3/25): $4.18    
Market cap (1/3/25): $267 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 43 pages Larimar Therapeutics, Inc. Sales Agreement
12/34/56
EX-10.21
from 10-K 16 pages First Amendment to Lease
12/34/56
EX-10.20
from 10-K 70 pages Lease Between Bala Plaza Property, Inc., Landlord, and Chondrial Therapeutics, Inc., a Delaware Corporation, Tenant August 8, 2019
12/34/56
EX-10.4
from 10-K 7 pages Larimar Therapeutics, Inc. Non-Qualified Stock Option Grant Notice and Award Agreement Non-Plan Inducement Award
12/34/56
EX-10.3
from 10-K 5 pages Restricted Stock Unit Award Agreement for Company Employees Under the Larimar Therapeutics, Inc. 2020 Equity Incentive Plan Incremental Number of Restricted Stock Units Vested Vesting Date
12/34/56
EX-10.1
from 10-Q 17 pages Employment Agreement
12/34/56
EX-10
from 10-K 16 pages Second Amendment to Master Services Agreement
12/34/56
EX-10
from 10-K 7 pages Larimar Therapeutics, Inc. Non-Qualified Stock Option Grant Notice and Award Agreement Non-Plan Inducement Award
12/34/56
EX-10
from 10-K 5 pages Restricted Stock Unit Award Agreement for Company Employees Under the Larimar Therapeutics, Inc. 2020 Equity Incentive Plan Incremental Number of Restricted Stock Units Vested Vesting Date
12/34/56
EX-10.2
from 10-Q Pdf Courtesy Copy
12/34/56
EX-10.2
from 10-Q 3 pages Third Amendment to License Agreement
12/34/56
EX-10.1
from 10-Q Pdf Courtesy Copy
12/34/56
EX-10.1
from 10-Q 3 pages Second Amendment to License Agreement
12/34/56
EX-10.3
from 8-K 19 pages Amended and Restated Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 38 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 2 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. First Amendment to Master Services Agreement
12/34/56
EX-10.1
from 10-Q 22 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. Master Services Agreement
12/34/56
EX-10.1
from 8-K 85 pages Recitals Terms
12/34/56
EX-10.2
from 8-K 4 pages Larimar Therapeutics, Inc. 2020 Equity Incentive Plan Stock Option Grant Notice and Award Agreement
12/34/56